Clinical Trial Update: Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer [NA]

View source ↗

Summary

Clinical trial evaluating cetuximab with radiation therapy for advanced head and neck squamous cell carcinomas has terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx | NA | Status: TERMINATED | Results posted: 2021-01-15